KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Assets (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 2.12%
Dec 31, 2025 0.49%
Sep 30, 2025 2.55%
Jun 30, 2025 -1.64%
Mar 31, 2025 -2.69%
Dec 31, 2024 1.05%
Sep 30, 2024 -0.03%
Jun 30, 2024 -2.23%
Mar 31, 2024 -4.30%
Dec 31, 2023 7.31%
Sep 30, 2023 0.29%
Jun 30, 2023 1.75%
Mar 31, 2023 36.24%
Dec 31, 2022 2.23%
Sep 30, 2022 7.43%
Jun 30, 2022 0.17%
Mar 31, 2022 -3.22%
Dec 31, 2021 -5.89%
Sep 30, 2021 8.73%
Jun 30, 2021 -4.42%
Mar 31, 2021 -0.65%
Dec 31, 2020 -2.61%
Sep 30, 2020 -0.58%
Jun 30, 2020 5.42%
Mar 31, 2020 3.29%
Dec 31, 2019 0.29%
Sep 30, 2019 0.27%
Jun 30, 2019 -7.23%
Mar 31, 2019 -3.64%
Dec 31, 2018 -1.36%
Sep 30, 2018 -0.52%
Jun 30, 2018 -4.89%
Mar 31, 2018 -10.99%
Dec 31, 2017 -0.47%
Sep 30, 2017 0.93%
Jun 30, 2017 2.22%
Mar 31, 2017 0.30%
Dec 31, 2016 -0.67%
Sep 30, 2016 3.55%
Jun 30, 2016 0.47%
Mar 31, 2016 5.13%
Dec 31, 2015 -0.58%
Sep 30, 2015 0.93%
Jun 30, 2015 3.27%
Mar 31, 2015 -0.08%
Dec 31, 2014 -2.50%
Sep 30, 2014 1.78%
Jun 30, 2014 3.78%
Mar 31, 2014 1.33%
Dec 31, 2013 15.86%
Sep 30, 2013 8.48%
Jun 30, 2013 1.88%
Mar 31, 2013 -4.90%
Dec 31, 2012 -2.07%
Mar 31, 2010 1.86%
Dec 31, 2009 -3.20%
Sep 30, 2009 5.41%